Notas de prensa
- Sin apartado
- General
Amgen to Present at the 26th Annual JP Morgan Healthcare Conference
THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Jan. 4, 2008--Amgen (NASDAQ:AMGN) will participate in the 26th Annual JP Morgan Global Healthcare Conference on Tuesday, Jan. 8, 2008, at the Westin St. Francis in San Francisco, Calif., beginning at 7:30 a.m. Pacific Time. Amgen Chairman and CEO Kevin Sharer will present at the conference. Live audio of the presentation will be available over the Internet and can be accessed from Amgen´s Web site, www.amgen.com, under Investors.
Information regarding presentation time, webcast availability, and webcast links are available on Amgen´s Investor Relations Events Calendar.
About Amgen
Amgen discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science´s promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people´s lives. To learn more about our pioneering science and our vital medicines, visit www.amgen.com.
CONTACT: Amgen, Thousand Oaks David Polk, 805-447-4613 or 805-490-0661 (media) Cory Rivera, 805-447-1060 (investors) SOURCE: Amgen
![El 45% de los pacientes con hipofosfatemia ligada al cromosoma X (XLH) padece hipertensión arterial, un porcentaje significativamente mayor al de la población general[1]](https://farmanews.com/images/user_no_photo2.jpg)
